Follow
Dr. Krishnan Namboori P. K.
Dr. Krishnan Namboori P. K.
Associate Professor, Amrita Molecular Modeling And Synthesis (AMMAS) research lab, Amrita Vishwa
Verified email at cb.amrita.edu - Homepage
Title
Cited by
Cited by
Year
Basis sets
KI Ramachandran, D Gopakumar, K Namboori
Computational Chemistry and Molecular Modeling: Principles and Applications …, 2008
5702008
The ApoE gene of Alzheimer's disease (AD)
PKK Namboori, KV Vineeth, V Rohith, I Hassan, L Sekhar, A Sekhar, ...
Functional & integrative genomics 11, 519-522, 2011
452011
Detection of multi-class retinal diseases using artificial intelligence: an expeditious learning using deep CNN with minimal data
S Karthikeyan, KP Sanjay, RJ Madhusudan, SK Sundaramoorthy, ...
Biomedical & Pharmacology Journal 12 (3), 1577, 2019
332019
Healthcare security using blockchain for pharmacogenomics
M Abraham, AH Vyshnavi, C Srinivasan, PK Namboori
Journal of International Pharmaceutical Research 46 (1), 529-533, 2019
212019
Targeting a conserved pocket (n-octyl-β-D–glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors
KNPKSJ P. Naresh,A. Selvaraj,P. Shyam Sundar,S. MurugesanORCID Icon,S ...
Journal of Biomolecular Structure and Dynamics, DOI: 10.1080/07391102.2020 …, 2020
16*2020
Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach
PM Iyer, S Karthikeyan, P Sanjay Kumar, PK Krishnan Namboori
Functional & integrative genomics 17, 375-385, 2017
162017
‘BRCA1’ RESPONSIVENESS TOWARDS BREAST CANCER-A POPULATION-WISE PHARMACOGENOMIC ANALYSIS
PKKN Preethi M. Iyer, Sanjay Kumar P., Karthikeyan S.
International Journal of Pharmacy and Pharmaceutical Sciences 8 (9), 266-270, 2016
16*2016
Evaluation of colorectal cancer (CRC) epidemiology a pharmacogenomic approach
AM HimaVyshnavi, OM Deepak, PKK Namboori
Journal of Young Pharmacists 9 (1), 36, 2017
152017
Deep convolution network based prediction model for medical diagnosis of lung cancer-a deep pharmacogenomic approach: Deep diagnosis for Lung Cancer
A Iyer, HV AM, KN PK
2018 Second international conference on advances in electronics, computers …, 2018
112018
Evaluation of kaempferol as AKT dependent mTOR regulator via targeting FKBP-12 in hepatocellular carcinoma: an in silico approach
P Siniprasad, B Nair, V Balasubramaniam, P Sadanandan, PK Namboori, ...
Letters in Drug Design & Discovery 17 (11), 1401-1408, 2020
102020
Tumor hypoxia Diagnosis using deep CNN learning strategy a theranostic pharmacogenomic approach
B Vaisali, CR Parvathy, HV AM, KN PK
International Journal of Prognostics and Health Management 10 (3), 2019
92019
Thyroid Cancer Prediction Using Gene Expression Profile, Pharmacogenomic Variants And Quantum Image Processing In Deep Learning Platform-A Theranostic Approach
V Sajeev, AMH Vyshnavi, PKK Namboori
2020 International Conference for Emerging Technology (INCET), 1-5, 2020
82020
Prediction of epigenetic variations in Alzheimer's disease-identification of ethnic variants through pharmacogenomic approach
PMIPKKN Sanjaykumar P, S Karthikeyan
Research Journal of Pharmaceutical, biological and chemical sciences 7 (4 …, 2016
82016
Design and development of potential flavonoid moiety for Pbp2a inhibition for Mrsa therapy-A computational technique
M Sangeetha, TS Saranya, S Sathianarayanan, HV AM, PKK Namboori
Biomedical and Pharmacology Journal 13 (2), 687-692, 2020
62020
Individual variation in p53 responsiveness:a pharmacogenomic approach
AGNKNPK Anusooya N J, Krishnapriya A S, Deepak O M
World journal of Pharmacy and pharmaceutical sciences 3 (2), 2059-2069, 2014
62014
De Novo designing of HDAC inhibitors in cancer therapy
CP Anju, NJ Anusooya, M Deeasree, OM Deepak, PKK Namboori
International Journal of Pharmaceutical Science and Health Care 2, 59-66, 2012
62012
Insilico Analysis of Nano Polyamidoamine (PAMAM) Dendrimers for Cancer Drug Delivery
R Radhika, V Rohith, NC Anil Kumar, K Varun Gopal, ...
Int. J. Recent Trends Eng. Technol 4, 142-144, 2010
62010
Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach.
KNPKSKM Jubie Selvaraj,Shyam Sundar P,Logesh Rajan,Divakar Selvaraj,Dhanabal ...
RSC Advances 11, 13051-13060, 2021
52021
An Ai driven genomic profiling system and secure data sharing using Dlt for cancer patients
V Iyer, AMH Vyshnavi, S Iyer, PKK Namboori
2019 IEEE Bombay Section Signature Conference (IBSSC), 1-5, 2019
52019
Design of Novel Drug Molecules for the Treatment of Breast Cancer
Vijith V S, Harikrishnan K,Krishnan Namboori P K
International Journal of Pharmaceutical Sciences Review and Research 20 (2 …, 2013
52013
The system can't perform the operation now. Try again later.
Articles 1–20